Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning.

Journal: Journal of Alzheimer's disease : JAD
PMID:

Abstract

BACKGROUND: Detecting early-stage Alzheimer's disease in clinical practice is difficult due to a lack of efficient and easily administered cognitive assessments that are sensitive to very mild impairment, a likely contributor to the high rate of undetected dementia.

Authors

  • Michael J Kleiman
    Comprehensive Center for Brain Health, Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Elan Barenholtz
    Center for Complex Systems and Brain Sciences, Florida Atlantic University, Boca Raton, Florida 33431, United States.
  • James E Galvin
    Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Miami, FL, United States.